These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23736139)

  • 1. "Colloid twice daily" is not fluid resuscitation! Inappropriate inclusion of clinical trials in meta-analyses may distract from gaps in evidence.
    Kranke P; Roewer N; Muellenbach RM
    Intensive Care Med; 2013 Aug; 39(8):1503. PubMed ID: 23736139
    [No Abstract]   [Full Text] [Related]  

  • 2. Harm associated with 6 % tetrastarch 130 kDa [hydroxyethyl starch (HES) 130/0.4 and 130/0.42] is robust to sensitivity analysis by excluding Dolecek et al.
    Patel A; Waheed U; Brett SJ
    Intensive Care Med; 2013 Aug; 39(8):1507-8. PubMed ID: 23736140
    [No Abstract]   [Full Text] [Related]  

  • 3. Randomised trials of 6% tetrastarch (hydroxyethyl starch 130/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis.
    Patel A; Waheed U; Brett SJ
    Intensive Care Med; 2013 May; 39(5):811-22. PubMed ID: 23430019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the literature inconclusive about the harm from HES? No.
    Wiedermann CJ; Bellomo R; Perner A
    Intensive Care Med; 2017 Oct; 43(10):1523-1525. PubMed ID: 27007101
    [No Abstract]   [Full Text] [Related]  

  • 5. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.
    Gosling P; Rittoo D; Manji M; Mahmood A; Vohra R
    Lancet; 2001 Aug; 358(9281):581; author reply 582. PubMed ID: 11526921
    [No Abstract]   [Full Text] [Related]  

  • 6. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.
    Godet G
    Lancet; 2001 Aug; 358(9281):581; author reply 582. PubMed ID: 11526922
    [No Abstract]   [Full Text] [Related]  

  • 7. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.
    Boldt J
    Lancet; 2001 Aug; 358(9281):581-3. PubMed ID: 11526920
    [No Abstract]   [Full Text] [Related]  

  • 8. Hydroxyethyl starch for resuscitation.
    Haase N; Perner A
    Curr Opin Crit Care; 2013 Aug; 19(4):321-5. PubMed ID: 23743591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Not Available].
    Hahn R
    Lakartidningen; 2018 May; 115():. PubMed ID: 29738050
    [No Abstract]   [Full Text] [Related]  

  • 10. Fluid resuscitation with hydroxyethyl starches in patients with sepsis is associated with an increased incidence of acute kidney injury and use of renal replacement therapy: a systematic review and meta-analysis of the literature.
    Serpa Neto A; Veelo DP; Peireira VG; de Assunção MS; Manetta JA; Espósito DC; Schultz MJ
    J Crit Care; 2014 Feb; 29(1):185.e1-7. PubMed ID: 24262273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetrastarch solutions: are they definitely dead?
    Moral V; Aldecoa C; Asuero MS
    Br J Anaesth; 2013 Sep; 111(3):324-7. PubMed ID: 23946355
    [No Abstract]   [Full Text] [Related]  

  • 12. Hydroxyethyl-starch use and PBM: a necessary update to the Italian national guidelines.
    Biancofiore G; Vaglio S; Liumbruno GM
    Blood Transfus; 2016 May; 14(2):195-6. PubMed ID: 27177414
    [No Abstract]   [Full Text] [Related]  

  • 13. Faulty risk-of-bias assessment in a meta-analysis of hydroxyethyl starch for nonseptic ICU patients.
    Bayer O; Reinhart K
    Crit Care; 2015 Oct; 19():357. PubMed ID: 26446864
    [No Abstract]   [Full Text] [Related]  

  • 14. Faulty risk-of-bias assessment in a meta-analysis of hydroxyethyl starch for non-septic ICU patients: a rebuttal.
    James M; Joubert I; Michell WL; Nicol A; Navsaria P; Gillespie R
    Crit Care; 2015 Dec; 19():444. PubMed ID: 26699365
    [No Abstract]   [Full Text] [Related]  

  • 15. Why hydroxyethyl starch solutions should NOT be banned from the operating room.
    De Hert S; De Baerdemaeker L
    Anaesthesiol Intensive Ther; 2014; 46(5):336-41. PubMed ID: 25432553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the literature inconclusive about the harm from HES? Yes.
    Ertmer C; Annane D; Van Der Linden P
    Intensive Care Med; 2017 Oct; 43(10):1520-1522. PubMed ID: 27007102
    [No Abstract]   [Full Text] [Related]  

  • 17. Is the literature inconclusive about the harm of HES? We are not sure.
    Schetz M; Shaw AD; Vincent JL
    Intensive Care Med; 2017 Oct; 43(10):1526-1528. PubMed ID: 27007103
    [No Abstract]   [Full Text] [Related]  

  • 18. Is 6% tetrastarch 130kDa (hydroxyethyl starch 130/0.4 or 130/0.42) suitable for severe sepsis?
    Patel A; Brett SJ
    Br J Hosp Med (Lond); 2013 Mar; 74(3):178. PubMed ID: 23665793
    [No Abstract]   [Full Text] [Related]  

  • 19. Is fluid resuscitation with high-volume hydroxyethyl starch safe for the kidney in trauma patients?
    Xue FS; Liu GP; Li RP; Sun C
    Injury; 2015 Aug; 46(8):1698-9. PubMed ID: 25823537
    [No Abstract]   [Full Text] [Related]  

  • 20. But is it safe? Hydroxyethyl starch in perioperative care.
    Greenberg S; Tung A
    Anesth Analg; 2015 Mar; 120(3):519-521. PubMed ID: 25695570
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.